A bipartisan group of 20 U.S. senators has called for federal coverage of antiamyloid antibodies approved to treat Alzheimer’s disease.
Source: Drug Industry Daily
Senators Join in Bipartisan Push for Antiamyloid Antibody Coverage
- Post author:PacConAdmin
- Post published:February 22, 2023
- Post category:Drug Industry Daily